END-STAGE RENAL DISEASE (ESRD)
Clinical trials for END-STAGE RENAL DISEASE (ESRD) explained in plain language.
Never miss a new study
Get alerted when new END-STAGE RENAL DISEASE (ESRD) trials appear
Sign up with your email to follow new studies for END-STAGE RENAL DISEASE (ESRD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for dialysis patients: testing a Longer-Lasting lifeline
Disease control Recruiting nowThis study is testing a new type of artificial blood vessel, called the InnAVasc graft, for people with kidney failure who need dialysis. The goal is to see if this graft is safe and stays open long enough to be a reliable access point for dialysis treatments. Researchers will fo…
Matched conditions: END-STAGE RENAL DISEASE (ESRD)
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Can your smartphone improve dialysis care?
Disease control Recruiting nowThis study is testing whether a phone app can help people on long-term kidney dialysis manage their health better. About 400 patients will either use the app for personalized health tips and reminders or receive their usual care. Researchers will compare the two groups to see if …
Matched conditions: END-STAGE RENAL DISEASE (ESRD)
Phase: NA • Sponsor: Yunfeng Xia • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
FDA-Approved device monitored for Long-Term dialysis safety
Disease control Recruiting nowThis study is collecting long-term safety and performance information on an already FDA-approved device called EndoForce. The device is used to connect a dialysis graft to a vein in patients with end-stage kidney disease. Researchers will follow 150 patients to see how well the c…
Matched conditions: END-STAGE RENAL DISEASE (ESRD)
Sponsor: Phraxis, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Puncture instead of surgery: new device aims to simplify dialysis access
Disease control Recruiting nowThis study is testing a new device called the Velocity System that creates a dialysis access point using a small skin puncture and a catheter, avoiding traditional open surgery. It will enroll 126 adults with kidney failure who need dialysis access to see if this less invasive me…
Matched conditions: END-STAGE RENAL DISEASE (ESRD)
Phase: NA • Sponsor: Venova Medical • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Dialysis exercise study: when is best to work out?
Symptom relief Recruiting nowThis study aims to find the best time for physical therapy for people receiving dialysis treatment. Researchers will compare exercising during dialysis sessions versus exercising before dialysis starts. The goal is to see which timing leads to better improvements in walking abili…
Matched conditions: END-STAGE RENAL DISEASE (ESRD)
Phase: NA • Sponsor: Mohammad Arian • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
Can a Plant-Based diet help feed failing kidneys?
Symptom relief Recruiting nowThis study is testing whether a diet focused on plant foods can improve nutrition and health in malnourished adults who are on peritoneal dialysis for kidney failure. Researchers will compare the plant-focused diet to the standard kidney diet over 6 months to see which is better …
Matched conditions: END-STAGE RENAL DISEASE (ESRD)
Phase: NA • Sponsor: National University of Malaysia • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
Tweaking dialysis fluid to calm blood cells
Knowledge-focused Recruiting nowThis study is trying to understand if the recipe of the fluid used in dialysis machines affects blood inflammation and clotting. It will involve 15 patients already in a related trial. Researchers will test three different fluid recipes and collect blood samples to see how white …
Matched conditions: END-STAGE RENAL DISEASE (ESRD)
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
First human test: how kidneys handle new drug
Knowledge-focused Recruiting nowThis is an early safety study to understand how a new drug, LY3537031, moves through and leaves the body. It will compare people with healthy kidney function to those with severe kidney impairment or kidney failure. The main goal is to measure drug levels in the blood and check f…
Matched conditions: END-STAGE RENAL DISEASE (ESRD)
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:26 UTC